Pharmaceutical tablet
Latest Hanmi Pharm. Co., Ltd. Patents:
- LIVER-TARGETED SUBSTANCE AND USE THEREOF
- Lyophilized formulation of long-acting human growth hormone immunoglobulin conjugate
- LIVER-TARGETED DRUG AND USE THEREOF
- Crystal form of acid addition salt of furopyrimidine compound
- METHOD FOR PREPARING ORAL COMPOSITE TABLET CONTAINING PROTON PUMP INHIBITOR AND ANTACID AND ORAL COMPOSITE TABLET PREPARED THEREBY
Description
The portions shown in broken lines do not form part of the claimed design and are hereby disclaimed.
Claims
The ornamental design for a pharmaceutical tablet, as shown and described.
Referenced Cited
U.S. Patent Documents
1243501 | October 1917 | Fraser |
4503031 | March 5, 1985 | Glassman |
D303160 | August 29, 1989 | Tovey |
5395625 | March 7, 1995 | Tang |
D397507 | August 25, 1998 | Bern |
D447835 | September 11, 2001 | Whitaker et al. |
D516714 | March 7, 2006 | McAllister et al. |
D553414 | October 23, 2007 | Boutin |
D556319 | November 27, 2007 | Chen et al. |
D557797 | December 18, 2007 | Stawski et al. |
Patent History
Patent number: D700315
Type: Grant
Filed: Jan 23, 2013
Date of Patent: Feb 25, 2014
Assignee: Hanmi Pharm. Co., Ltd. (Gyeonggi-Do)
Inventors: Dong Ho Kim (Gyeonggi-do), Ki Boong Lee (Gyeonggi-do)
Primary Examiner: Ian Simmons
Assistant Examiner: Charles Hanson
Application Number: 29/443,875
Type: Grant
Filed: Jan 23, 2013
Date of Patent: Feb 25, 2014
Assignee: Hanmi Pharm. Co., Ltd. (Gyeonggi-Do)
Inventors: Dong Ho Kim (Gyeonggi-do), Ki Boong Lee (Gyeonggi-do)
Primary Examiner: Ian Simmons
Assistant Examiner: Charles Hanson
Application Number: 29/443,875
Classifications
Current U.S. Class:
Scored For Dosage Control (D24/103)